Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis
- PMID: 6467679
- PMCID: PMC1536266
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis
Abstract
Sera from 39 patients with systemic sclerosis were examined for a cytotoxic effect on human umbilical vein endothelium. Although none of the sera produced direct cytotoxicity of 51Cr-labelled endothelial cells, even with added complement, nine sera did produce increased 51Cr release when co-cultured with endothelial cells and normal human peripheral blood mononuclear cells. The effector cells involved in this cytotoxicity possessed Fc receptors but were non-T and non-adherent while the responsible serum factor(s) was present in IgG containing fractions. This cytotoxicity tended to occur in patients with both circulating immune complexes and precipitating antibodies to nuclear and cytoplasmic antigens who, as a group, had more severe and extensive visceral disease than those without such serological abnormalities. Control studies using sera from both 27 normal controls and 19 patients with either diabetes or extensive athero-sclerotic vascular disease failed to reveal any similar cytotoxicity.
Similar articles
-
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus.J Clin Lab Immunol. 1985 Jul;17(3):125-30. J Clin Lab Immunol. 1985. PMID: 3876447
-
Serum-induced enhancement of peripheral blood mononuclear cell-mediated cytotoxicity towards human target cells in systemic sclerosis.J Clin Lab Immunol. 1983 Oct;12(2):77-81. J Clin Lab Immunol. 1983. PMID: 6644792
-
Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic sclerosis.Clin Exp Immunol. 1979 Apr;36(1):175-82. Clin Exp Immunol. 1979. PMID: 466860 Free PMC article.
-
Serum-induced enhancement of peripheral blood mononuclear cell mediated cytotoxicity towards human target cells in systemic lupus erythematosus.J Clin Lab Immunol. 1983 Jun;11(2):81-5. J Clin Lab Immunol. 1983. PMID: 6876144
-
Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.J Clin Invest. 1995 Dec;96(6):2569-77. doi: 10.1172/JCI118320. J Clin Invest. 1995. PMID: 8675620 Free PMC article.
Cited by
-
Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis. II. Effector cells for the enhancing effect of acroscleroderma patients' sera.Arch Dermatol Res. 1988;280(7):395-8. doi: 10.1007/BF00429976. Arch Dermatol Res. 1988. PMID: 2462852
-
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis.Ann Rheum Dis. 2024 Mar 12;83(4):543-546. doi: 10.1136/ard-2023-225174. Ann Rheum Dis. 2024. PMID: 38135464 Free PMC article. No abstract available.
-
Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis.Clin Exp Immunol. 1986 Apr;64(1):94-100. Clin Exp Immunol. 1986. PMID: 3089652 Free PMC article.
-
Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.Ann Rheum Dis. 1997 Apr;56(4):230-4. doi: 10.1136/ard.56.4.230. Ann Rheum Dis. 1997. PMID: 9165994 Free PMC article.
-
Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?Front Immunol. 2022 Jun 28;13:930970. doi: 10.3389/fimmu.2022.930970. eCollection 2022. Front Immunol. 2022. PMID: 35837382 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical